nice tirzepatide obesity What NICE's (mounjaro) treatment recommendation means for primary care The Benefits of Using Tirzepatide

Although previous studies showed a lack of therapeutic benefit for GIP agonists, current studies show that the glucose lowering and weight loss effects of tirzepatide are at least as effective as GLP-1 RAs with a similar adverse effect profile

Wait at least 30 minutes before eating, drinking or taking other tablets to allow proper absorption

Always store them away from heat, light, and shaking to protect stability

Its safety profile is similar to existing incretin-based therapies, making it a particularly promising candidate for obesity, type 2 diabetes, and related metabolic conditions

Wegovy (semaglutide) is an FDA-approved GLP-1 receptor agonist used for chronic weight management in eligible adults

The compound does not need to be administered at the same time each day, but maintaining a consistent weekly schedule improves adherence